- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT06256458
Prospektivt register for å evaluere resultater av NanoBone® beintransplantasjon ved akutt traume (ARTIST)
Multisenter prospektivt register for å evaluere bruk og resultater av NanoBone® bengraftsubstitutt hos pasienter med akutte traumer
This multicenter prospective patient registry was developed with the aim of documenting how orthopedic surgeons are utilizing the NanoBone products in acute trauma cases along with relevant patient outcomes. These outcomes include radiographic measures such as fracture healing, instrumentation integrity, and clinical outcomes (symptom and function improvement) based on investigator and patient-based outcome assessments.
Studieoversikt
Detaljert beskrivelse
This multicenter prospective patient registry was developed with the aim of documenting how orthopedic surgeons are utilizing the NanoBone products in acute trauma cases along with relevant patient outcomes. These outcomes include radiographic measures such as fracture healing, instrumentation integrity, and clinical outcomes (symptom and function improvement) based on investigator and patient-based outcome assessments.
The primary objective of this study is to document and analyze the use of NanoBone products in acute trauma cases (as a stand-alone bone graft, or in combination with local bone only, no other bone graft substitute or biologic product used) and determine both radiographic success and clinical outcomes. All product related adverse events will be documented, tabulated, and summarized.
Studietype
Registrering (Antatt)
Kontakter og plasseringer
Studiekontakt
- Navn: James J Cassidy, Ph.D.
- Telefonnummer: 320-259-4321
- E-post: jcassidy@artossinc.com
Studiesteder
-
-
Wisconsin
-
Madison, Wisconsin, Forente stater, 53715
- Rekruttering
- SSM Health St. Mary's Hospital
-
Ta kontakt med:
- Mitchell D Kuhl, DO
- Telefonnummer: 608-294-6464
- E-post: mitch.kuhl@ssmhealth.com
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Prøvetakingsmetode
Studiepopulasjon
All patients in the study will be drawn from the individual surgeons' practice. Patients will be among those already surgically treated for trauma but have not completed their standard of care follow-up as determined by the surgeon's practice. In addition, the surgeon had determined that the use of a NanoBone product was clinically necessary for the patient. The choice of a NanoBone product was independent of this research project. Only patients who have had NanoBone implanted and consent to participate and meet the inclusion-exclusion criteria will be included in the registry.
Beskrivelse
Inclusion Criteria:
-
Subjects at least 18 years old at the time of injury
-
Acute fractures, resulting from blunt or penetrating trauma
- In the extremities or pelvis
- Requiring surgery
- Treated emergently, delayed or staged up to 4 weeks from the date of injury
- Where bone grafting is clinically indicated
Exclusion Criteria:
-
Certain fracture locations (these apply to non-unions as well)
- Hand - metacarpals, phalanges
- Forefoot - metatarsals, phalanges
- Skull
- Spine
-
Fractures requiring definitive fracture stabilization beyond the initial 4 weeks from the date of injury
-
Pathologic fractures secondary to malignancy
-
Subjects unable to follow recommended post-operative plan and complete follow ups
-
Subjects unable to complete patient reported outcome measures
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Observasjonsmodeller: CASE_ONLY
- Tidsperspektiver: PROSPECTIVE
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Radiographic evidence of fracture healing
Tidsramme: 2 weeks, 6 weeks, 3 months, 6 months
|
AP and lateral x-rays |
2 weeks, 6 weeks, 3 months, 6 months
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Pain relief
Tidsramme: 2 weeks, 6 weeks, 3 months, 6 months
|
Visual Analog Scale (VAS) pain score at fracture site. 0-10 scale, lower score means less pain. |
2 weeks, 6 weeks, 3 months, 6 months
|
Samarbeidspartnere og etterforskere
Sponsor
Etterforskere
- Hovedetterforsker: Mitchell D Kuhl, DO, SSM Health
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- ART001
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
produkt produsert i og eksportert fra USA
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .